H
Hecto Innovation Co Ltd
KOSDAQ:214180
Hecto Innovation Co Ltd
KOSDAQ:214180
Price:
12 560
KRW
2.03%
Market Closed
Market Cap:
166.5B
KRW
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
Alert
Hecto Innovation Co Ltd
12560
+250 (+2.03%)
| 52 Week Range |
11 630
14 850
|
| Price Target |
|
We'll email you a reminder when the closing price reaches KRW.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Hecto Innovation Co Ltd
Balance Sheet
Balance Sheet Decomposition
Hecto Innovation Co Ltd
Hecto Innovation Co Ltd
| Current Assets | 519.4B |
| Cash & Short-Term Investments | 328.3B |
| Receivables | 171.7B |
| Other Current Assets | 19.4B |
| Non-Current Assets | 147.1B |
| Long-Term Investments | 32.8B |
| PP&E | 16.3B |
| Intangibles | 83.9B |
| Other Non-Current Assets | 14.1B |
| Current Liabilities | 323.5B |
| Accounts Payable | 1.4B |
| Accrued Liabilities | 10.4B |
| Short-Term Debt | 10B |
| Other Current Liabilities | 301.7B |
| Non-Current Liabilities | 151.2B |
| Long-Term Debt | 4.2B |
| Other Non-Current Liabilities | 146.9B |
Balance Sheet
Hecto Innovation Co Ltd
Hecto Innovation Co Ltd
Currency: KRW
| Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
7 005
|
29 534
|
33 868
|
99 144
|
95 089
|
94 623
|
120 622
|
190 605
|
172 878
|
180 704
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
2
|
2
|
3
|
2
|
2
|
|
| Cash Equivalents |
7 005
|
29 534
|
33 868
|
99 144
|
95 089
|
94 621
|
120 620
|
190 602
|
172 876
|
180 702
|
|
| Short-Term Investments |
3 874
|
6 800
|
16 689
|
12 272
|
14 844
|
61 420
|
58 670
|
49 864
|
47 979
|
74 861
|
|
| Total Receivables |
3 024
|
6 846
|
10 671
|
16 462
|
20 089
|
25 864
|
39 148
|
60 988
|
123 564
|
151 697
|
|
| Accounts Receivables |
2 894
|
4 096
|
8 735
|
10 983
|
13 939
|
15 156
|
16 815
|
19 887
|
22 589
|
26 284
|
|
| Other Receivables |
130
|
2 750
|
1 936
|
5 479
|
6 150
|
10 708
|
22 333
|
41 101
|
100 975
|
125 413
|
|
| Inventory |
0
|
0
|
0
|
0
|
378
|
0
|
11 833
|
7 675
|
9 854
|
10 670
|
|
| Other Current Assets |
983
|
95
|
248
|
466
|
985
|
21 310
|
1 934
|
10 811
|
11 109
|
6 267
|
|
| Total Current Assets |
14 886
|
43 274
|
61 475
|
128 344
|
131 386
|
203 217
|
232 207
|
319 943
|
365 384
|
424 200
|
|
| PP&E Net |
543
|
609
|
8 427
|
2 294
|
3 156
|
8 299
|
13 333
|
10 049
|
18 384
|
10 906
|
|
| PP&E Gross |
543
|
609
|
8 427
|
2 294
|
3 156
|
8 299
|
13 333
|
10 049
|
18 384
|
10 906
|
|
| Accumulated Depreciation |
90
|
243
|
3 162
|
2 975
|
3 722
|
6 097
|
11 204
|
16 181
|
17 527
|
23 643
|
|
| Intangible Assets |
1 583
|
4 988
|
56 392
|
52 145
|
48 832
|
45 502
|
62 206
|
57 553
|
56 360
|
51 089
|
|
| Goodwill |
0
|
0
|
15 808
|
15 145
|
15 145
|
15 746
|
18 622
|
23 859
|
37 494
|
36 544
|
|
| Note Receivable |
0
|
160
|
152
|
129
|
279
|
656
|
1 665
|
3 804
|
3 763
|
4 302
|
|
| Long-Term Investments |
216
|
663
|
15 741
|
13 457
|
32 404
|
26 561
|
30 207
|
36 170
|
40 322
|
43 124
|
|
| Other Long-Term Assets |
1 067
|
1 156
|
2 278
|
1 884
|
1 712
|
1 013
|
3 604
|
2 676
|
5 104
|
5 928
|
|
| Other Assets |
0
|
0
|
15 808
|
15 145
|
15 145
|
15 746
|
18 622
|
23 859
|
37 494
|
36 544
|
|
| Total Assets |
18 294
N/A
|
50 850
+178%
|
160 273
+215%
|
213 398
+33%
|
232 913
+9%
|
300 993
+29%
|
361 845
+20%
|
454 054
+25%
|
526 811
+16%
|
576 094
+9%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
0
|
0
|
0
|
95
|
304
|
0
|
390
|
326
|
905
|
2 747
|
|
| Accrued Liabilities |
142
|
188
|
1 462
|
1 932
|
2 496
|
3 863
|
3 703
|
5 434
|
9 831
|
9 886
|
|
| Short-Term Debt |
0
|
0
|
5 030
|
100
|
0
|
0
|
2 000
|
577
|
675
|
470
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
1 302
|
2 867
|
2 295
|
5 424
|
4 233
|
|
| Other Current Liabilities |
1 752
|
3 708
|
25 342
|
61 786
|
63 088
|
67 311
|
95 235
|
153 754
|
200 605
|
239 963
|
|
| Total Current Liabilities |
1 894
|
3 897
|
31 834
|
63 913
|
65 888
|
72 476
|
104 195
|
162 385
|
217 440
|
257 298
|
|
| Long-Term Debt |
3 452
|
0
|
65
|
0
|
2 000
|
3 679
|
1 991
|
357
|
8 493
|
6 271
|
|
| Deferred Income Tax |
11
|
0
|
9 942
|
10 704
|
10 043
|
8 795
|
12 498
|
14 653
|
13 556
|
11 946
|
|
| Minority Interest |
0
|
0
|
39 771
|
43 672
|
51 707
|
88 286
|
112 213
|
137 754
|
142 561
|
126 346
|
|
| Other Liabilities |
2 014
|
0
|
2 062
|
1 465
|
1 586
|
1 282
|
1 652
|
2 732
|
4 718
|
5 775
|
|
| Total Liabilities |
7 371
N/A
|
3 897
-47%
|
83 674
+2 047%
|
119 754
+43%
|
131 224
+10%
|
174 518
+33%
|
232 549
+33%
|
317 881
+37%
|
386 768
+22%
|
407 636
+5%
|
|
| Equity | |||||||||||
| Common Stock |
2 000
|
2 859
|
3 370
|
6 739
|
6 739
|
6 739
|
6 739
|
6 789
|
6 789
|
6 789
|
|
| Retained Earnings |
10 539
|
19 340
|
28 007
|
39 750
|
51 187
|
65 747
|
78 260
|
95 421
|
120 498
|
137 808
|
|
| Additional Paid In Capital |
134
|
26 876
|
52 570
|
47 878
|
48 038
|
59 824
|
59 489
|
45 206
|
25 926
|
44 838
|
|
| Unrealized Security Profit/Loss |
0
|
0
|
0
|
49
|
1 612
|
2 477
|
1 942
|
1 655
|
2 691
|
1 711
|
|
| Treasury Stock |
0
|
2 105
|
7 308
|
0
|
1 988
|
2 734
|
12 598
|
12 356
|
15 272
|
22 059
|
|
| Other Equity |
1 750
|
16
|
39
|
674
|
674
|
624
|
654
|
541
|
589
|
628
|
|
| Total Equity |
10 923
N/A
|
46 953
+330%
|
76 599
+63%
|
93 644
+22%
|
101 690
+9%
|
126 475
+24%
|
129 296
+2%
|
136 173
+5%
|
140 043
+3%
|
168 458
+20%
|
|
| Total Liabilities & Equity |
18 294
N/A
|
50 850
+178%
|
160 273
+215%
|
213 398
+33%
|
232 913
+9%
|
300 993
+29%
|
361 845
+20%
|
454 054
+25%
|
526 811
+16%
|
576 094
+9%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
9
|
11
|
12
|
13
|
13
|
13
|
12
|
13
|
13
|
12
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
